Chaetocin can directly bind to TKT, inhibiting its enzyme activity and expression, interfering with intracellular metabolism and oxidation-reduction balance, and then regulating the PI3K/Akt signaling pathway to inhibit the growth of NSCLC and induce apoptosis. The gene discussed is TKT; the disease is non-small cell lung carcinoma.